Abstract:Introduction Two million older Americans from underrepresented racial and ethnic minority groups (URGs) have early-stage Alzheimer's disease and related dementias (ADRD). Recent neuroimaging and clinical trials focus on individuals with early-stage ADRD, which is crucial to the development of disease modification strategies. Despite recognition of the need to increase URG engagement in these studies, enrollment remains low. A major barrier to improving URG participation rates is the lack of best practices in recruitment and referral processes. The aim of these analyses was to take a first step in examining reasons for these disparities by comparing referral sources for ADRC enrollment of URG participants with early-stage ADRD. Methods These analyses included data from 48,330 participants across 46 ADRCs, obtained through the National Alzheimer's Coordinating Center Uniform Data Set. Descriptive statistics from 5 racial/ethnic groups at baseline (visit 1) were compared using one-way analysis of variance models (ANOVAs) and chi-square tests. Generalized multinomial logistic regression models were used to examine the association of racial/ethnic group and the types of referral sources (professional, non-professional and other), with ‘non-professional’ as the reference category. The ‘professional’ category included referrals made by healthcare professionals or ADRC staff, while the ‘non-professional’ category included referrals made by family and friends. This association was examined in three samples: (1) the entire sample, (2) individuals with a baseline diagnosis of mild cognitive impairment (MCI) or dementia and a baseline global Clinical Depression Rating (CDR) of 0.5 or 1, and (3) individuals who had completed magnetic resonance imaging (MRI) at any point and a baseline diagnosis of MCI or dementia and a baseline global CDR of 0.5 or 1. Significance was set at p <0.05. Results Descriptive statistics are shown in Table 1. The sample included 35,358 (73.2%) Non-Hispanic White participants, 4,138 (8.6%) Hispanic participants, 6,766 (14%) Non-Hispanic Black participants, 1,392 (2.9%) Non-Hispanic Asian participants, and 676 (1.4%) participants of other racial and ethnic groups. Across the entire sample, Non-Hispanic Black participants were less likely to be referred by a professional contact than Non-Hispanic White participants, but more likely to be referred by family or friends (Table 2). A similar pattern was observed in participants who had a diagnosis of MCI or dementia and a global CDR of 0.5 or 1 at baseline - both overall (Table 3) and in those who had completed MRI (Table 4). These findings remained significant after adjusting for age, gender, education, and CDR score. Conclusions A lack of healthcare professional-facilitated recruitment may contribute to the disproportionately lower research participation in URGs in early-stage ADRD, including those who are willing to complete investigations such as MRI. There is a need at a national level to develop recruitment strategies to increase URG representation, particularly for Non-Hispanic Black older adults. Further studies are needed to examine how factors affecting health equity may contribute to this disparity.

Expanding the scope of health disparities research in Alzheimer's disease and related dementias

Promoting diverse perspectives: Addressing health disparities related to Alzheimer's and all dementias

Rural-Urban Disparities of Alzheimer's Disease and Related Dementias: A Scoping Review

Expanding Representation of Low and Middle Income Countries in Global Dementia Research: Commentary From the Alzheimer's Association

Mapping racial and ethnic healthcare disparities for persons living with dementia: A scoping review

Estimating prevalence of early symptomatic Alzheimer's disease in the United States

Advancing Research on Diversity and Disparities Among Aging Adults

Racial and Ethnic Disparities in Participation at Alzheimer's Disease Research Centers

Identifying Gaps and Barriers in Alzheimer's Disease and Related Dementia Research and Management in Low- and Middle-Income Countries: A Survey of Health Professionals and Researchers

FROM THE WHO RESEARCH PRIORITIES AND RESEARCH PORTFOLIO ANALYSIS TO THE IDENTIFICATION OF RESEARCH GAPS TO REDUCE THE GLOBAL BURDEN OF DEMENTIA

Special Session Best of 2023: Care of the elderly

Promoting diversity in clinical trials: insights from planning the ALUMNI AD study in historically underrepresented US populations with early symptomatic Alzheimer's disease

Preserved Consciousness in Alzheimer’s Disease and Other Dementias: Caregiver Awareness and Communication Strategies

Social Determinants of Health for Alzheimer's Disease and Other Dementias

Referral Sources Across Racial and Ethnic Groups at Alzheimer's Disease Research Centers

Racial Disparities in Subjective Cognitive Decline and its Implications among Alzheimer's Caretakers

2022 Alzheimer's disease facts and figures

The Consortium for Clarity in ADRD Research Through Imaging (CLARiTI)

Chronic neuropsychiatric sequelae of SARS‐CoV‐2: Protocol and methods from the Alzheimer's Association Global Consortium

Dementia Research in 2022: Advancing Steadily on Reflection

Recent contributions to the field of subjective cognitive decline in aging: A literature review